Atopy from food allergies to environmental factors can increase hair loss prevalence among children and adults, according to ...

HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...

HCW Biologics Inc. has announced the FDA's approval of its Investigational New Drug Application to begin a Phase 1 clinical trial for HCW9302, a new immunotherapy targeting alopecia areata ...

Alopecia areata causes sudden hair loss and can have a significant negative impact on patients’ quality of life and psychological health. HCW9302 is an injectable, first-in-kind interleukin 2 (“IL-2”) ...

According to the National Alopecia Areata Foundation (NAAF), about 7 million people in the United States have alopecia areata. The condition primarily affects individuals under the age of 30, ...

Spc. Imani Gayle, a truck driver in the New Jersey Army National Guard, shares her journey of living with alopecia while serving in the military. She discusses the challenges she faced ...

The National Science Foundation canceled dozens of review panels Monday for research grant applications, according to emails obtained by POLITICO’s E&E News. The pause went into effect one day ...

The National Science Foundation canceled all of its grant review panels this week, as the organization works to align its grantmaking process with new executive orders from the Trump administration.